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HyperspectralHyperspectral imaging uses spectral and spatial image information for target detection and classiﬁcation. In this
work hyperspectral autoﬂuorescence imaging was applied to patient olfactory neurosphere-derived cells, a cell
model of a human metabolic disease MELAS (mitochondrial myopathy, encephalomyopathy, lactic acidosis,
stroke-like syndrome). By using an endogenous source of contrast subtle metabolic variations have been detect-
ed between living cells in their full morphological context which made it possible to distinguish healthy from
diseased cells before and after therapy. Cellular maps of native ﬂuorophores, ﬂavins, bound and free NADH and
retinoids unveiled subtle metabolic signatures and helped uncover signiﬁcant cell subpopulations, in particular
a subpopulation with compromised mitochondrial function. Taken together, our results demonstrate that multi-
spectral spectral imaging provides a new non-invasive method to investigate neurodegenerative and other
disease models, and it paves the way for novel cellular characterisation in health, disease and during treatment,
with proper account of intrinsic cellular heterogeneity.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Olfactory neurosphere (ONS) cells are easily accessible, patient-
derived models of neurological disease [1]. They are harvested from
the human olfactory mucosa, the organ of smell in the nose, which
regenerates throughout life. This neural tissue is accessible in human
adults and it demonstrates disease-dependent cell biology alterations
in Alzheimer's and Parkinson's diseases, Rett syndrome, fragile X syn-
drome, schizophrenia, MELAS and other diseases [2–8]. The analysis of
such cells provides new routes for the understanding of the pathogene-
sis of complex neurodegenerative conditions. Relative to other tissue
neurons exhibit intense metabolic demands, therefore impairment of
cellular metabolism accompanies many neurodegenerative diseases.
Thus new methods are required to characterise and quantify metabo-
lism of neural and other cells and tissue on a single cell level. Such
methods are important for accurate early diagnosis, treatmentmonitor-
ing and the development of therapies..
. This is an open access article underImaging of endogenous cell ﬂuorophores including nicotinamide
adenine dinucleotide (NADH), nicotinamide adenine dinucleotide
phosphate (NADPH), ﬂavin adenine dinucleotide (FAD) and ﬂavin
mononucleotide (FMN) to investigate cell metabolism has been
pioneered by Chance et al.[9]. By using optical microscopy techniques,
these autoﬂuorescent compounds can be easily observed providing
insights into metabolic activity in cells without altering them with
exogenous labels [10–27]. Multiphoton and ﬂuorescence lifetime imag-
ing microscopy (FLIM) have been the leading methods of cellular auto-
ﬂuorescence imaging with pioneering works by Skala et al. [10–12],
Gratton et al.[15–20], and others. Multiphoton and FLIM imaging
make it possible to determine the relative amounts of FAD and reduced
NADH and to distinguish their free and protein-bound forms. This has
been used to document increased glycolysis in cancer cells [10–12].
Although quantitative analysis of autoﬂuorescence has been previously
explored in multiphoton and FLIM modalities, there has been no
previous in-depth work concerned with single photon excited ﬂuo-
rescence. This simple approach provides clinically relevant information,
and it can be carried out by using unsophisticated, low cost
instrumentation.
Here we report the application of hyperspectral autoﬂuorescence
analysis to functional, metabolic imaging of patient-derived ONSthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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commonly attributed to the m.3243A N Gmitochondrial DNA (mtDNA)
point mutation within the MT-TL1 gene [28–31]. This mutation is
thought to disrupt respiratory chain complex assembly as reﬂected by
impaired mitochondrial protein synthesis [28] and reduced mitochon-
drial respiratory chain enzyme activities [29]. Mitochondrial dysfunc-
tion follows, with studies reporting reduced mitochondrial membrane
potential, with a parallel increase in reactive oxygen species production
leading to reduced ATP production [32] and induction of mitochondrial
permeability [29]. Cellular damage is apparent too, with increased gly-
colytic rate, impaired NADH response, decreased glucose oxidation
and increased lactate production [31]. This defective oxidativemetabol-
ic state is thought to inﬂuence the clinical expression of disease. Because
highly metabolic cells such as myocytes and neurons are highly depen-
dent on efﬁcient mitochondrial function, the percentage of mutant
mtDNA relative to wild-type mtDNA known as the “mutational load”
is important for determining whether the cell will be affected by the
mutation or not. This poorly understood phenomenon known as
heteroplasmy, the existence of both wild-type and mutant mtDNA
within a cell or tissue is unique to mitochondriopathies. Earlier studies
have demonstrated that highmutational load is detrimental tometabo-
lism. Thus the analysis method that is able to yield quantitative insights
concerning metabolism of individual live cells as well as their popula-
tions is a valuable tool to improve the understanding of this and other
mitochondrial diseases. This work demonstrates that a simple
hyperspectral imaging system coupled to a conventional wide-ﬁeld
microscope and high content analysis of the images provides novel
insights into cell metabolic signatures, their heterogeneity and MELAS
disease biology.
This study examines the effect of MELAS mutational load and
the shift in heteroplasmydue to galactose treatment on cellmetabolism.
To this aim we have cultured ONS cells from both control and
MELAS patients with greatly varying low (11%) and high (44%) muta-
tional loads. We have subsequently exposed them to galactose-
supplemented medium which has been shown to cause a reduction
in mutational load [33,34]. The cells were imaged to observe their
autoﬂuorescence characteristics. Throughout this work, hyperspectral
autoﬂuorescence images of live cells have been obtained at a number
of excitation wavelength ranges between 334 and 495 nm (each
approximately 10 nm wide). The emission is detected in the range
570 nm–605 nm. More details are described in the Methods section
and in Supplementary Material S1–S5.Fig. 1. Spectral projections of autoﬂuorescent properties of ONS cells. Controls 1 and2, 11%MELA
cells form statistically separate clusters with respect to autoﬂuorescence properties. a) Scatter p
spectra for each cell; the colour of these small markers identiﬁes cell populations from diffe
44% MELAS); cyan triangles: 11% MELAS; dark green crosses: 11% MELAS galactose treated; pin
within the single standarddeviation from themean values for each cell population; (b–g) histog
Numbers in brackets give statistical distance; p-values for class separation are less than 10−12
green, control 1 — green (1.97); d) 11% MELAS — cyan, 11% MELAS galactose treated — dark
MELAS galactose treated — blue, control 2 — red (1.23); g) 44% MELAS — pink, control 2 — red
data have been projected (see Supplementary Section S4.1).2. Results
2.1. Hyperspectral imaging can distinguish MELAS patients from healthy
controls and sheds light on the effectiveness of galactose treatment
We present the results of hyperspectral autoﬂuorescence character-
isation of the ONS cells with low (11%) and high (44%)mutational loads
of the m.3243A N G MELAS mutation (“MELAS ONS cells”) and corre-
sponding control cells (control 1 for 11% and control 2 for 44% MELAS
mutational load, respectively). Hyperspectral data correlations have
been removed by using PCA as described in Supplementary Material
Section S4. Subsequently, average cell spectra (represented here by
single data points) have been plotted in a two-dimensional spectral
space produced by the linear discriminant analysis (LDA, see Supple-
mentary Material S4). These are presented in Fig. 1 a where the axes
represent the directions onto which the cellular data have been
projected by LDA. The LDA optimally separates the three groups of
cells: healthy cells from both controls 1 and 2, 11% mutant MELAS and
44% mutant MELAS cells.
Clear separation of clusters observed in Fig. 1 a indicates that the
cells from MELAS patients can be distinguished from control cells.
Moreover, the cells from two different MELAS patients also form differ-
ent clusters, thus all three cell classes are well separated. To statistically
analyse the cluster separations, a second LDA projection of cell data
was carried out [35]. For this new projection, two classes of cells were
chosen at a time, and their average spectra were projected onto a com-
mon line. This approach visualises cell distributions by histograms
(Fig. 1 b–g). We found that every pair of classes selected among control,
MELAS, MELAS galactose treated cell classes gave p-values in the
Kolmogorov–Smirnov test of less than 10−12, consistently with Fig. 1
a [36,37]. The Kolmogorov–Smirnov test if passed with p b 0.05 allows
us to reject the null hypothesis that the samples are drawn from the
same distribution.
Themultispectral autoﬂuorescence analysis of cells that have under-
gone galactose treatment to reducemutational load is shown in Fig. 1 a.
In thisﬁgure, the clusters ofMELAS treated cells are located between the
control population and the MELAS population. The histograms
produced by pairwise LDA projections are signiﬁcantly different as
shown in Fig. 1 d–g. Thus multispectral imaging makes it possible to
distinguish MELAS ONS cells from control cells and also quantiﬁes the
response of such cells to pharmacological interventions.S and 44%MELAS aswell as 11%MELAS galactose treated and 44%MELAS galactose treated
lot of average cell spectra in optimised spectral space. Smallmarkers represent average cell
rent patients. Green circles: control1 cells (for 11% MELAS); red circles: (control 2 for
k triangles: 44% MELAS; blue crosses: 44% MELAS galactose treated cells. Ovals — regions
rams (Parzen estimates, see SupplementaryMaterial S4) of the selected pairs of cell classes.
; b) 11% MELAS — cyan, control 1 — green (1.87); c) 11% MELAS galactose treated— dark
green (1.15); e) 44% MELAS — pink, 44% MELAS galactose treated — blue (8.33); f) 44%
(2.08). Spectral variables are distance measures along the directions onto which the cell
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In order to shed light on biochemistry of the ONS cells we
decomposed the spectral images of the cells under investigation into
ﬁve most signiﬁcant spectral components representing themost prom-
inent ﬂuorophore groups. This analysis uses an unsupervised unmixing
approach (see Methods and Supplementary Material Section S4.2 for
details). The resulting component (endmember) spectra are shown in
Fig. 2 a–e (44% MELAS). The corresponding data for 11% MELAS are
shown in Sup. Fig S2. The endmember spectra are found to closely
correspond to the spectra of bound (red shifted) ﬂavins, FAD and/or
spectrally similar FMN, A2E, bound NADH, free NADH, and lipofuscin,
the most abundant cellular ﬂuorophores according to the literature
[15]. All groups of cells had signiﬁcant contributions of free and bound
NADH as well as A2E and lipofuscin. The ﬁfth spectral component was
different in 11% MELAS and 44% MELAS cells. We found FAD/FMN in
the group of 11% MELAS, 11% treated and control 1 ONS cells but
bound ﬂavins were prominent in the group of 44% MELAS, 44% MELAS
treated and control 2 ONS cells.
To verify our assignment we carried out colocalisation analysis of
autoﬂuorescence endmembers with organelle stained images (Sup.
Figs. S3, S4). An adaptive algorithm was used to correct for cell motion
occurring between autoﬂuorescence imaging and subsequent organelle
(mitochondria and lysosome) staining. The image correlations between
the endmembers and individual stains are displayed in Sup. Fig. S4Fig. 2. Label-free imaging of biochemistry in 44%MELAS cells. a–e: Comparison of the excitation
in our images byunsupervised unmixing (black). Our endmembers agreewellwith (a) bound (r
images of cells showing the abundance of the ﬁve key ﬂuorophores in control 2 (f–j), 44%MELA
ﬂavins; g, l,q—A2E;h,m, r— boundNADH; i,n, s— freeNADH; j,o, t— lipofuscin. Cellswere rand
clarity. The colour scale reﬂects ﬂuorophore concentration (abundance).indicating (a) high degree of colocalisation between (bound) ﬂavins
and stained mitochondria; (b) the absence of colocalisation between
free NADH bound NADH (correlation coefﬁcient r of 0.17); (c) strong
colocalisation of bound NADH and the mitochondria, with the values
of r between 0.62 and 0.9; and (d) co-localisation of retinoids with the
lysosomes and mitochondria.
Finally, we explored whether the identiﬁed ﬂuorophores appropri-
ately respond to chemical interventions. To this aim we applied several
known ﬂuorescence quenchers including (a) sodium borohydride
which reduces free NAD+ to ﬂuorescent NADH and reduces ﬂuorescent
ﬂavins thus quenching their ﬂuorescence; (b) acrylamide which
quenches ﬂavins; and (c) FCCP and rotenone, both speciﬁcally
quenching NADH [38,39]. Their effect on the ﬂuorescence intensity is
shown in Sup. Fig. S5. Fig. S6 shows a comparison of hyperspectral
unmixing with ﬂuorescence lifetime imaging (FLIM) in cells treated
with H2O2 where we observed similar trends.
Our approach produced cellular maps of each of the ﬁve key
ﬂuorophore groups within the examined cells. These are shown in
Fig. 2 f–t where we present images of the 44% MELAS ONS cells before
and after galactose treatment as well as the control ONS cells (see
Fig. S2 for 11% MELAS). We note that ﬂavins in MELAS ONS cells
(Fig. 2 k and Fig. S2 k) are concentrated in ﬁlamentous structures
surrounding the nucleus. Retinoids in control ONS cells (Fig. 2 g, j and
Fig. S2 g, j) form perinuclear rings consistent with their mitochondrial
localisation [14,40] with some contributions from the lysosomes asspectra ofﬁve keyﬂuorophores (red) in 44%MELASONS cellswith endmembers identiﬁed
ed shifted)ﬂavins, (b) A2E, (c) boundNADH, (d) freeNADH and (e) lipofuscin.We present
S (k–o) and 44%MELAS treated ONS cells (p–t). Columns from left to right: f, k, p— bound
omly selected and their outlines determinedusing top 3 PCA imageshave beenmarked for
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in all examined cells are shown in Sup. Fig. S7. These data indicate
that MELAS ONS cells present a ﬂuorophore proﬁle that reﬂects altered
metabolism, different to control ONS cells, while galactose treatment
appears to modify the ﬂuorophore proﬁle of the treated MELAS cells.
2.3. Identiﬁcation of cell subpopulations
We used our automated algorithm described in Methods to search
for cell subpopulations by looking for clustering of ﬂuorophore abun-
dances. All combinations of features have been tested and scored in
terms of howwell they clustered indicating subpopulation coincidence.
This was done for all features shown to have deﬁnite one-dimensional
subpopulations.
Interestingly, we found two uneven well-separated subpopulations
for 11% MELAS (red and blue symbols, Fig. 3 a), and two similar size
equally well-separated subpopulations for 44% MELAS (yellow and
green symbols, Fig. 3 b). Statistical analysis of these and other subpopu-
lations before and after galactose treatment is shown in Sup. Fig. S8. We
also draw attention to the behaviour of the optical redox ratio, in partic-
ular the ratio of ﬂavins to boundNADH (Sup. Fig. S8) showing clear sub-
populations in MELAS ONS cells. These subpopulations disappear after
galactose treatment. The ratio of free to boundNADHwhich is a relative
measure of glycolysis and several other features also shows clear
subpopulations (Sup. Fig. S8).
2.4. Biochemical differences between the examined cell groups
Sup. Fig. S9 summarises the results of biochemical characterisation
of the examined cell groups. It shows that the biochemistry of MELAS
cells is signiﬁcantly altered compared to healthy controls. For example
the ATP production andMTMP inMELAS cells are lower than in healthy
controls, while the levels of lactate and SOX are elevated. These values
return closer to those in control cells after treatment. These results are
consistentwith signiﬁcant differences observed in the autoﬂuorescence
properties of these cell groups.
3. Discussion
3.1. Hyperspectral imaging enables differentiation of cell groups
Hyperspectral analysis to differentiate cell groups enables to statisti-
cally establish that MELAS ONS cells differ from control cells. The ONS
cells from each MELAS patient before and after galactose treatment
can also be distinguished (Fig. 1 a). This is consistentwith earlier studies
showing that galactose treatment enhances mitochondrial metabolism.
We and others have shown improved mitochondrial function with
exposure of diseased cells to galactose by shifting the mutational load
of diseased cells [33,34]. The mechanism by which cells shift in muta-
tional load is unknown, however, selective apoptosis in combination
with cell proliferation and mitophagy for surviving cells may reduce
the mutational load of cells.
The method presented here produces p-values for the hypothesis
that the two cell groups are different. It is also robust with respect to
reproducibility and the same results have been obtained in repetitive
cell experiments from different cell passages carried out four months
apart (data not shown). These results also show that hyperspectral
analysis of cellular autoﬂuorescence is sensitive enough to monitor
functional treatment response of ONS cells from single individuals.
3.2. Hyperspectral imaging enables biochemically sensitive functional
imaging of cells
In addition to cell classiﬁcations, our hyperspectral dataset provides
detailed insights into cell biochemistry. The ﬂuorescence of unlabelled
cells is produced by endogenous ﬂuorophores including NADHand NAD(P)H, riboﬂavin and ﬂavin–coenzymes including FAD and
FMN, retinol and other retinoids including components of lipofuscin,
pyridoxine, vitamin B12, vitamin D, ceroid, cytochromes, vitamin K,
tryptophan, tyrosine, phenylalanine, kynurenine and porphyrins, as
well as the complexes of these ﬂuorescent molecules with proteins
[19,20,26,41–47]. Among these ﬂuorophores protein-bound and free
NAD(P)H produces a signiﬁcant part of the ﬂuorescence signal
responding to excitation in the 330–390 nmwavelength range. Flavins
are prominent in the longer wavelength range (excitation peaks at
360 nm and at 440–450 nm, emission in the range 450–600 nm) with
parts of their spectra well separated from the NAD(P)H group. Reti-
noids, especially retinol can also be observed, in particular lipofuscin
and A2E tend to be highly visible [19,20,41]. Previous studies of autoﬂu-
orescence in cells indicate the absence of ﬂuorophore quenching; this
means that ﬂuorophore concentration is proportional to ﬂuorescence
intensity. In particular, a linear correlation has been shown between
total NADH content determined biochemically and NADH ﬂuorescence,
[42,43]. The total NADH concentration is typically in 100 μM range [44].
Other ﬂuorophores listed here are less abundant, for example ﬂavins are
present in cells at ~50 μM [45], and the most abundant retinoid, retinol
at 1–2 μMconcentrations. Retinoic acid, anhydroretinol and retinal have
lower concentrations; all are below the onset of concentration
quenching [26], while lipofuscin can form highly concentrated granules.
Unlike in other works [14] our spectra have sufﬁcient spectral reso-
lution to differentiate between unbound and protein-bound forms of
NADH, whose spectrum is blue-shifted by 20 nm compared to free
NADH [46,47]. However we are unable to differentiate between NADH
and NADPH, thus the NADH components in this work (free or bound)
represents both NADH and NADPH ﬂuorescence [26]. The bound ﬂavin
component represents the majority of the cellular ﬂavins' ﬂuorescence
produced by the mitochondrial lipoamide dehydrogenase (LipDH) and
electron transfer ﬂavoprotein (ETF), but also any other bound ﬂavins.
The shape of the bound ﬂavin excitation spectrum observed here is
similar to that of aqueous solution of riboﬂavin, with a red shift by
50 nm by the effect of protein binding [38,48–50]. We have been able
to separately identify FAD, but it could not be separated from spectrally
similar FMN [14]. In the retinoid group, the A2E has also been separately
identiﬁed, while the spectrally similar retinoids [51,52] (retinol, retinoic
acid, cellular retinol-binding proteins (CRBPs), and cellular retinoic
acid-binding proteins (CRABPs)) have been merged with lipofuscin.
3.3. Trends in ﬂuorophore content
Here, we discuss the trends observed in various cellular characteris-
tics between control, MELAS and MELAS treated cells. We ﬁrst discuss
the ﬂuorophore content presented in Fig. S7 which shows that
the 44% MELAS cells show signiﬁcantly more bound ﬂavin ﬂuores-
cence than the controls. The 11% MELAS cells seem to contain mostly
FAD/FMN instead of bound ﬂavins and the increase of FAD/FMN in
MELAS cells is much less pronounced. Mitochondriopathies often lead
to accumulation of reduced forms of FAD, NADH and FMN, as they can-
not bind to the respiratory chain proteins [53]. In mitochondriopathies
such asMELASwhich affects assembly of respiratory chain proteins, it is
expected that at high mutational loads (such as 44%), we would ﬁnd
reduced forms of FAD and FMN (all ﬂavins) present at higher levels
when compared to control cells. However, at lower mutational loads
(such as 11%) this effect is expected to be less pronounced, because
the assembly of proteins may not be as disrupted as it is at higher mu-
tational loads. The build-up of reactive oxygen species also conﬁrmed
in our experiment (Fig. S9)may change the ﬂavin redox balance and in-
crease ﬂavin ﬂuorescence.
The trends in free and bound NADH content in the examined cells
are complicated, with 44% MELAS cells showing a slight increase of
bound NADH compared to controls (Fig. S7), while 11% MELAS cells
show slightly less bound NADH and slightly more free NADH than the
respective control cells. These complex trends need to be reconciled
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cells [11]. However this increase has been reported only in cells with
intact, functioning mitochondria. While MELAS ONS cells do exhibit
higher levels of glycolysis than control cells (Fig. S9), they may have
decreased mitochondrial numbers at certain mutational loads. In such
cells, the amount of NADH present under glycolysis conditions may
depend upon the overall cytosolic pool size of NAD+ and NADH, and
may bear no simple relation to the amount of NADH in the control
cells. The relatively higher levels of bound NADH in 44% than in 11%
MELAS cells (Fig. S9) could be consistent with a higher mitochondrial
activity combined with a smaller mitochondrial mass, resulting in a
similar ATP production, with a slightly reduced production of lactate,
and a much higher superoxide generation.
3.4. Discussion of speciﬁc cell subpopulations
Here we discuss cell populations visualised by scatterplots in Fig. 3
and those statistically analysed in Fig. S8. For 44% MELAS, Fig. 3 b
shows two distinctive populations with different metabolic proﬁles
(yellow and green symbols) where the “blue” cells have a generally
higher ratio of free to bound NADH, and they also have a higher average
lipofuscin. These cells constitute ~41% of the total, consistent with
44% mutational loading, and they form a completely separated cluster.
Fig. 3 a displays subpopulations uncovered in 11% MELAS ONS cells
(red and blue symbols). These two populations have similar character-
istics as those in 44% MELAS. Cells in the small cluster comprising
7% cells (red symbols) has a high ratio of free NADH to bound NADH
and a majority of cells (blue symbols) have a much lower free to
bound NADH ratio. The red cells have comparatively high levels of
lipofuscin. We do not know at this point whether these metabolically
different “red” and “yellow” cells are carrying themutations; this should
be investigated further.
The behaviour of subpopulations before and after treatment is
shown in Fig. S8. This ﬁgure shows the plots of bound ﬂavin versus
bound NADH content for control, 44% MELAS and 44% MELAS treated
cells. We can see here that control cells form two fairly tight popula-
tions, with bound ﬂavins' abundance varying in the range of 0.2 to 2.2.
In contrast, the MELAS cells form very distinctive populations, one
with low bound ﬂavins (between 0 and 3) and a group of cells which
could be still mutated with an unusually high bound ﬂavin content
(between 5 and 20). After treatment, the high bound ﬂavins' group
completely disappears and the remaining cells form a single population
spreading over the same region of abundances as the control cells. Sup.
Fig. S8 also shows the populations with respect to the free and bound
NADH content. Again, we observe two well-deﬁned subpopulations
in control cells. The MELAS cells also show two populations, one ofFig. 3. Scatterplots showing the most pronounced correlations between ﬂuorophore abundanc
are indicated on the axes. Ovals are guide for the eye only, to highlight cell populations.which has a much higher free NADH content that the control cells.
After treatment only a single population is observed. Sup. Fig. S8
shows similar trends in the ﬂuorophore ratios, again displaying clear
subpopulations in most cases. These subpopulations are particularly
pronounced in MELAS cells for bound ﬂavins to bound NADH ratio.
These subpopulations are associated with varying levels of metabolic
activity.
The data in Fig. 3 and Sup. Fig. S8 are consistent with the view that
MELAS cells in this patient belong to two distinctive classes. Thus our
data shed light on the hypothesis that MELAS is a disease which affects
cells to a different degree as opposed to the alternative hypothesis that
all cells are similar and characterised by a certain proportion of defective
mitochondria in each. Distinguishing between these two hypotheses is
signiﬁcant for the design of patients' treatment regimens.4. Conclusions
Originally developed for remote sensing, this work expands the
hyperspectral approach to the ﬁelds of medicine and cell biology in
areas utilising ﬂuorescence microscopy. It yields quantitative and
straightforward interpretation of physiological processes in living
tissues similar to multiphoton ﬂuorescence and/or FLIM but without
the complexity and cost of a multiphoton FLIM imaging system. The
use of single photon ﬂuorescence at comparatively low excitation
irradiances (in the order of 103 W/cm2) from light emitting diodes
makes this method compatible with in-vivo use.
We demonstrated that hyperspectral or multispectral imaging
provides richly detailed information about living cells which allows to
test hypotheses about similarity or otherwise of cell distributions and
about the effects of chemical interventions, in this case galactose
treatment.
We have been able to unambiguously decompose cellular autoﬂuo-
rescence into contributions from several most abundant ﬂuorophores
present in those cells, generate cellular maps and provide statistical in-
formation about cellular abundances of these ﬂuorophores. Although
we have not included here detailed analysis cellular distribution of
these ﬂuorophores, this method can be naturally extended to provide
combined morphological and chemical cellular features.
The information about average content of the most abundant
ﬂuorophores in each individual cell obtained in our method bears
some similarity to ﬂow cytometry measurements. Hundreds of cells
can be analysed in each experiment mostly automatically and there is
scope for full automation. This approach has allowed to identify biolog-
ically and functionally distinguishable cell subpopulations of potential
biological signiﬁcance.es in cells and cell subpopulations (a) in 11% MELAS cells, (b) in 44%MELAS. Fluorophores
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new windows into biological functions of individual living cells, and it
can detect and quantify their metabolic activity. Our approach
combined with high content data mining of cell images has provided
novel insights into the MELAS disease which is characterised by genet-
ically determined mitochondrial dysfunction. We have shown that the
new method can help assess the disease status and the effectiveness
of therapy. Olfactory neurosphere cells investigated here are regarded
as disease-speciﬁc models of neuronal disorders [1]. Using this method
it will be possible to analyse impairment of metabolic function in these
diseases. Thus hyperspectral analysis presented here may help to better
understand a broad range of diseases affecting metabolism including
neuronal degeneration.
5. Methods
See Supplementary Material for expanded description of methods.
5.1. Primary cell culture
In this study we used cells from the MELAS patient-derived
olfactory-derived neurospheres (ONS)with varying levels ofmutational
load (11% and 44%) generated from olfactory primary cultures. To
prepare these ONS, nasal biopsies were carried out and harvested cells
were expanded and subcultured as described in more details in Supple-
mentary Material S1. All biopsy tissues were obtained with informed
written consent of the patients and the study carried out under a proto-
col that was approved by the ethics committees of the Royal North
Shore Hospital and theUniversity of Sydney, according to the guidelines
of the National Health and Medical Research Council of Australia. Cells
from control subjects were harvested and treated in the same fashion.
The MELAS cells were subjected to galactose-supplemented, glucose-
free media (starvation) over a period of 4 days. We present data from
three different cell passages.
5.2. Microscopic imaging
Imaging was carried out on cells having an approximately constant
cell density. Each cell sample was prepared and imaged in duplicate.
Altogether, over 1500 cells were imaged in this study, between
350 and 400 for each patient (more details in Supplementary Material
S2 and S3).
5.3. Mitochondrial parameter assays
Cells were carefully characterised biologically by a variety of
methods. In particular we measured mutational load by standard
radiolabelled (“hot-ﬁnish”) PCR/RFLP analysis, carried out the citrate
synthase assay for the determination of mitochondrial mass, and mea-
sured the level of lactate, ATP, mitochondrial superoxide generation
(SOX), and mitochondrial transmembrane potential by ﬂow cytometry.
All cells were also imaged by laser scanning microscopy, with Green
Mitotracker, Red Lysotracker and Blue ER-Tracker staining (see Supple-
mentary Material S2 for more details).
5.4. Hyperspectral measurements technique
Our method uses ﬂuorescence of native ﬂuorophores commonly
found in cells. In our approach the images of live cells are obtained by
an Andor IXON camera under illumination at a number of selected
bands of excitation wavelengths (here, centred at 334, 365, 385, 395,
405, 415, 425, 435, 455, 475, 495 nm, each about 10 nm wide).
The emission is measured with a 532 nm long pass dichroic mirror
together with a 587 nm bandpass ﬁlter (35 nm bandwidth), in the
range 570 nm–605 nm. The spectra obtained in this way are excitation
spectra. This selection of excitation–emission channels with optimisedexposure times enables to capture images with sufﬁcient signal to
noise ratio for accurate unmixing of multiple cellular ﬂuorophores.
This includes free and bound NADH whose spectra have tails in the
570–605 nm range, however these compounds produce a signiﬁcant
proportion of the autoﬂuorescence signal at 334 nm excitation wave-
length. Optical powers at the objective ranged from 0.1 μW at 334 nm
excitation to 102 μWat 475 nm. Thesemeasurements yieldﬂuorescence
excitation spectra measured at each pixel for all images of cells coming
from all patients. These spectra are further corrected for instrumental
response. A “background” reference image of a culture dish with a
medium is also taken and subtracted from all images with cells.
5.5. Data analysis method for differentiation of cell groups
The original pixel spectra containing intensity andwavelength infor-
mation are represented as vectors in an n-dimensional spectral space
whose coordinates are intensities at each of the n excitationwavelength
(here, n = 11). This dataset contains signiﬁcant correlations, as cell
images at adjacent wavelengths are very similar; this is ﬁrst removed
by using a covariance matrix calculated from the data (see Supplemen-
taryMaterial S4 formathematical details). Further, we calculate average
cell spectra. The method of linear discriminant analysis (LDA)[35] is
then employed, in order to establish whether these average spectra
from biologically identiﬁable classes of cells form well separated clus-
ters. In this method we ﬁrst choose the m cell classes and by using
LDA we project the original n-dimensional spectral space and the data
points representing the average spectra of our cells onto a new, lower-
dimensional space. Its dimension is given by the number of groups of
cell classes to be distinguished less1. For convenience of presentation,
in this work we have been using three classes of cells, so that after
LDA the spectra of these cells can be depicted as points on two dimen-
sional plots. This two-dimensional spectral space produced by LDA is
referred to as the “canonical spectral space”. Its basis vectors are orthog-
onal, and aligned with the axes in our relevant ﬁgures.
The LDAmethod ensures that the new space is optimised to provide
the best degree of separation between selected cell classes (such as, for
example, cells from different patients). Finally, to quantify the distinc-
tiveness between selected pairs of cell clusters we perform the LDA
analysis again, on each pair of cell cluster data projecting them onto a
one-dimensional line. The Kolmogorov–Smirnov statistical test is then
applied to gauge and compare the similarity of the pair of clusters. We
also calculate the maximum Fisher statistical distance, a measure of
cluster closeness which is sensitive to cluster means and takes account
of the data dispersion.
We add that the data for additional cells and/or patients or data pro-
duced by other authorsmay beplotted togetherwith our data. Although
there is no mathematical certainty that optimum separation will be
achieved for such blended datasets, a clear separation may often be
achieved in the case when class distinction results are statistically
strong with small p-values.
5.6. Data analysis method to determine ﬂuorophore abundance
We are assuming that the observed spectra are a linear combination
of fundamental spectra originating from particular substances, called
endmembers. ThisN number of endmember spectra Xis weighted by
an abundance coefﬁcient vector f such that an observed spectrum
Zpwhich is given by Eq. (1):
Zp ¼ Xf þ e ¼
XN
i¼1Xi f i þ e ð1Þ
where e is the residual, or noise, not explained by the mixture of
endmembers.
The problem of ﬁnding the endmembers has a simple geometrical
interpretation. The spectra of all individual pixels in cells represent a
62 M.E. Gosnell et al. / Biochimica et Biophysica Acta 1863 (2016) 56–63certain cluster in anN dimensional space. The cluster is contained with-
in a convex hull called a simplex and each pixel spectrum point within
this simplex represents a linear combination of the spectra represented
by the extreme points (vertices) of that simplex. These vertex spectra
are chosen to be endmembers. See Supplementary Material
Section S4.2 for more details about identifying endmembers.
In order to ﬁnd the best simplex representing the data points two
conditions need to be satisﬁed: that the coefﬁcients of the abundance
vector are all positive and that they add to unity. To identify that best
simplex we minimised the least squares error between the target
spectra and the product of our abundance vector multiplied by the
endmember spectra, for the entire set of data. The corresponding
endmembers spectra are shown in Fig. 2 and Sup. Fig. S1. These are
identiﬁed to measured reference spectra of known ﬂuorescent
compounds in cells and/or to their spectra reported in the literature.
Fit errors are typically being between 5 and 10%, due to the presence
of other less abundant and unidentiﬁed residue spectra.
5.7. Data analysis method to detect cell subpopulations
In order to characterise subpopulations in the examined cells we
ﬁrst specify K, the number of subpopulations we wish to ﬁnd in each
data group (K=2 in the presented analysis). Then for all groupswithin
all variables, the data undergo an unsupervised mixture model. The
non-deterministic algorithm is used to break the data into potential
subpopulations. Each produced solution goes through selection criteria
so that only the highest scoring solution per data group is selected. The
criteria are that each of the subpopulations must be N30% of the whole
dataset, the subpopulations must have a statistical separation greater
than 1, and they must pass a Kolmogorov–Smirnov test with p b 0.05.
The mixture model returns only the subpopulation means and covari-
ance, so in order to classify the data points in one of the K subpopula-
tions we used a Naive Bayes classiﬁer. The method reproducibly ﬁnds
subpopulations that agree with intuition when looking at the histo-
grams. Boxplots are used to give an overview of data and a visualisation
has been created to display groups of data with subpopulations. The
width of the subpopulation boxes is proportional to their size, to allow
some inference power across groups.
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